Loading...
This week, NEJM Journal Watch and Physician's First Watch are bringing you coverage of study findings presented at the European Society of Cardiology's annual 2017 meeting in Barcelona, Spain. Here is a compilation of our coverage thus far, listed by date and title of meeting presentations, with the articles' first authors in parentheses. We will be updating this notice daily; you may wish to bookmark the URL.
(Your NEJM Journal Watch subscription is required, except where noted.)
Clinical Effects of Anacetrapib in People with Established Vascular Disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55–REVEAL) trial (The HPS3/TIMI55–REVEAL Collaborative Group)…